Mid-luteal progesterone testing through your doctor is the gold standard
Semaglutide, a GLP-1 receptor agonist, has been used for over a decade, while tirzepatide, a newer dual GLP-1/GIP receptor agonist, entered the market more recently with a distinct mechanism
That conversion applies to every number in the tables above
Studies suggest tirzepatide may help improve cardiometabolic risk factors and reduce the risk of atherosclerotic cardiovascular disease (CVD)
Others discover that the savings evaporate when accounting for testing costs, shipping delays, and occasional batches that fail to meet specifications
For those new to tirzepatide dosing in units , the escalation typically looks like this: 2.5mg for weeks 1-4, then 5mg for weeks 5-8, then 7.5mg for weeks 9-12, with optional increases to 10mg and 15mg for those who tolerate lower doses well but need additional appetite suppression